Day One Biopharmaceuticals, Inc. ($DAWN)
Filing Information
| Accession Number | 0001655962-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 30, 2026 |
| Document Date | Jan 30, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
314,000
Total Value
$0.00
P&L
+inf% (+$6,686,630.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COO and CFO | Stock Option (right to buy Common Stock) | Derivative | Jan 30, 2026 | Grant/Award | 188,000 | $0.00 | $0.00 | 188,000 | Direct | โ | View Details | |
COO and CFO | Restricted Stock Units | Derivative | Jan 30, 2026 | Grant/Award | 126,000 | $0.00 | $0.00 | 126,000 | Direct | โ | View Details |